TET2 and myeloid neoplasm: These phenotypes are consistent with prevalence of myeloid disorders and malignancies linked to Tet2 loss in adult mice (14, 41, 43) as well as with onset of more robust and aggressive myeloid malignancies associated with inducible combined deletion of Tet2 and Tet3 in adult mice (44).